DNA repair genes in Parkinson's disease

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 6, 2012, Pages 504-507

  Gencer, Mehmet ^a   Dasdemir, Selcuk ^b   Cakmakoglu, Bedia ^b   Cetinkaya, Yilmaz ^a   Varlibas, Figen ^a   Tireli, Hulya ^a   Kucukali, Cem Ismail ^b   Ozkok, Elif ^b   Aydin, Makbule ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CYSTEINE; DOPAMINE; GLUTAMINE; HISTIDINE; LYSINE; METHIONINE; REACTIVE OXYGEN METABOLITE; SERINE; THREONINE; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

ADULT; APE1 GENE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; DOPAMINERGIC NERVE CELL; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOGG1 GENE; HUMAN; HUMAN TISSUE; LOCUS CERULEUS; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; XPG GENE;

AGED; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84862995472     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0252     Document Type: Article

References (27)

1. Chinta SJ, Andersen JK (2008) Redox imbalance in Parkinson's disease. Biochim Biophys Acta 1780:1362-1367.
2. Coppedè F, Migliore L (2010) DNA repair in premature aging disorders and neurodegeneration. Curr Aging Sci 3:3-19.
3. Fahn S, Marsden CD, Goldstein M, Calne DB (1987) Recent Developments in Parkinson's Disease. Mc Millan, New York.
4. Griffin CS, Simpson PJ, Wilson CR, Thacker J (2000) Mammalian recombination- repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol 2:757-761.
5. Hirsch EC, Brandel JP, Galle P, et al. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56:446-451. (Pubitemid 21901982)
6. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442.
7. Hu JJ, Smith TR, Miller MS, et al. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22:917-922. (Pubitemid 32514958)
8. Jacobsen NR, Raaschou-Nielsen O, Nexo B, et al. (2004) XRCC3 polymorphisms and risk of lung cancer. Cancer Lett 213: 67-72. (Pubitemid 39118535)
9. Kökmen E, Naessens JM, Offord KP (1987) Short test of mental status: descriptive and preliminary results. Mayo Clin Proc 62:281-288. (Pubitemid 17052827)
10. Kolesnick R, Golde DW (1997) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328.
11. Krokan HE, Nilsen H, Skorpen F, et al. (2000) Base excision repair of DNA in mammalian cells. FEBS Lett 476:73-77. (Pubitemid 30394654)
12. Le Marchand L, Donlon T, Lum-Jones A, et al. (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 11:409-412. (Pubitemid 34408221)
13. Lees AJ (1988) The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:144-147.
14. Marnett LJ (2000) Oxyradicals and DNA damage. Carcinogenesis 21:361-370.
15. Matullo G, Palli D, Peluso M, et al. (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22:1437-1445. (Pubitemid 32898701)
16. Metsola K, Kataja V, Sillanpaa P, et al. (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 7:R987-R997.
17. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
18. Mort R, Mo L, McEwan C, Melton DW (2003) Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. Br J Cancer 89:333-337. (Pubitemid 36976325)
19. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144. (Pubitemid 29144883)
20. Pankratz N, Foroud T (2004) Genetics of Parkinson disease. NeuroRx 1:235-242. (Pubitemid 46589354)
21. Rao KS (2007) Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Practice Neurol 3:162-172.
22. Sturgis EM, Castillo EJ, Li L, et al. (1999) Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20:2125-2129. (Pubitemid 29535314)
23. Takanami T, Nakamura J, Kubota Y, Horiuchi S (2005) The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat Res 582:135-145. (Pubitemid 40386929)
24. Tell G, Damante G, Caldwell ID, Kelley MR (2005) The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antiox Redox Signal 7:367-384. (Pubitemid 40279805)
25. Wood RD, Mitchell M, Sgouros J, Lindahl T (2001) Human DNA repair genes. Science 291:1284-1289. (Pubitemid 32173086)
26. Yeh CC, Sung FC, Tang R, et al. (2005) Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 28:5-12.
27. Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147:93-104.